ANSELL LIMITED — Capital/Financing Update 2021

Apr 27, 2021

ASX

Announcement

==> picture [135 x 62] intentionally omitted <==

Ansell Limited Provides a Trading Update and Upgrades F’21 Guidance

28th April 2021 – Ansell Limited (ASX:ANN), the global leader in personal protection safety solutions, provides a trading update and upgrades its guidance for the full year ending 30th June 2021.

Ansell is continuing to support elevated demand for PPE around the world and our key capacity expansions remain on track to meet increased demand. Our financial performance since January 2021 has been stronger than expected. Specifically, we have the following items to highlight:

• Successful management of COVID-19 at all our manufacturing locations resulting in limited downtime or employee disruption to date;

• Continued increases in raw material and outsourced supplier costs for Exam/SU has been well managed through better than expected execution of price increases;

• Mechanical and Surgical SBUs which initially saw negative effects from COVID-19, have continued to deliver a faster and stronger comeback than previously foreseen and Chemical and Life Sciences continue to perform well;

• We have been able to continue to supply customers with product despite tightness in raw material supply and disruptions in ocean freight capacity which has resulted in an increase in transportation transit times; and

• Lower than anticipated travel and marketing spend given that travel restrictions still remain in place in many parts of the world.

Based on the above developments, we expect F’21 H2 year on year sales growth to be strong despite the solid performance of the prior comparable period and above 24.5% growth reported in F’21 H1. We also expect full year EPS to be in the range of US192¢ - US202¢ (up from previous guidance of US160¢ - US170¢ provided on 16th February 2021).

We will provide F’22 guidance on 24th August 2021 when we release our full year F’21 financial results.

This announcement has been authorised for release by the Board of Directors of Ansell Limited.

ENDS

==============================================================================

Ansell Limited, A.C.N. 004 085 330, Level 3, 678 Victoria Street, Richmond, Victoria 3121, Australia, Tel (+61 3) 9270 7270, F(+613) 9270 7300 www.ansell.com

ASX

Announcement

==> picture [135 x 62] intentionally omitted <==

For further information:

Investors & Analysts

Australia Anita Chow, Investor Relations Tel: +61 434 602 919 anita.chow@ansell.com Brussels Zubair Javeed, CFO Tel: +32 2528 7585 zubair.javeed@ansell.com Australia Tim Duncan, Hintons Tel: +61 408 441 122 tduncan@hintons.com.au

Media

About Ansell

Ansell is a world leader in providing superior health and safety protection solutions that enhance human well-being. The world’s need for better protection never stops, so Ansell is constantly researching, developing and investing to manufacture and distribute cutting edge product innovation and technology, marketed under well-known brands that customers trust.

Operating in two main business segments, Industrial and Healthcare, Ansell is the market leader that continues to grow, employing over 13,500 people worldwide. With operations in North America, Latin America/Caribbean, EMEA and Asia Pacific, customers in more than 100 countries around the world trust Ansell and its protection solutions.

Information on Ansell and its products can be found at www.ansell.com. #AnsellProtects

==> picture [124 x 24] intentionally omitted <==

==> picture [94 x 23] intentionally omitted <==

Ansell,[® ] and[TM ] are trademarks owned by Ansell Limited or one of its affiliates. US Patented and US and non-US Patents Pending: www.ansell.com/patentmarking © 2020 Ansell Limited. All Rights Reserved

Ansell Limited, A.C.N. 004 085 330, Level 3, 678 Victoria Street, Richmond, Victoria 3121, Australia, Tel (+61 3) 9270 7270, F(+613) 9270 7300 www.ansell.com